Roger's 1997 Short Picks Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Strategies & Market Trends : Roger's 1997 Short Picks

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Hank who wrote (6329)	10/30/1997 6:08:00 PM
From: Franco Battista	Read Replies (2) of 9285

One product companies in the drug sector, if they lack competition for long enough, can build up significant cash positions that then allow them to expand through acquisitions. The Vivus play is really quite simple. They are currently selling everything they produce. They are preparing to ramp up production in December. If they are successful their profits will increase in a big way. They will be trading at about 25 times earnings by the end of the next quarter, if they match last quarter's EPS of 31 cents. There is a possibility of several European and Asian countries approving their product soon. They have a head start on PFE. For this company to fail you would be betting that PFE will take most of vivus's business away when their drug Viagra is launched in about 1 year. You would be running the risk of holding your short while vivus ramped up production in the next several quarters. There are much better shorts out there. I sold a bunch of Dell Nov. 100 naked calls today, got 1$ for them! There is some easy money just lying around.

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next